Credit Suisse Raises Salix Pharmaceuticals Price Target By: Benzinga via Benzinga December 18, 2014 at 14:42 PM EST Credit Suisse raised its price target on Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) from $111 to $121 and maintained a Neutral ... Read More >>